The role of Vitamin D in infectious processes

Vitamin-Binding Proteins: Functional Consequences

Volumn , Issue , 2013, Pages 89-106

  Chesney, Russell W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054749541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15313     Document Type: Chapter

References (113)

1. Adams, J. S. 2006. Vitamin D as a defensin. J Musculoskelet Neuronal Interact 6: 344-6.
2. Adams, J. S., Hewison, M. 2008. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4: 80-90.
3. Adams, J. S., Hewison, M. 2011. Update in vitamin D. J Clin Endocrinol Metab 95: 471-8.
4. Arneil, G. C. 1975. Nutritional rickets in children in Glasgow. Proc Nutr Soc 34: 101-9.
5. Arshi, S., Ghalehbaghi, B., Kamrava, S. K., Aminlou, M. 2012. Vitamin D serum levels in allergic rhinitis: Any difference from normal population? Asia Pac Allergy 2: 45-8.
6. Banajeh, S. M., al-Sunbali, N. N., al-Sanahani, S. H. 1997. Clinical characteristics and outcome of children aged under 5 years hospitalized with severe pneumonia in Yemen. Ann Trop Paediatr 17: 321-6.
7. Belderbos, M. E., Houben, M. L., Wilbrink, B. et al. 2011. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 127: e1513-20.
8. Bennett, J. H. 1853 The Pathology and Treatment of Pulmonary Tuberculosis. 1st ed. Southerland and Knox, Edinburgh.
9. Berry, D. J., Hesketh, K., Power, C., Hypponen, E. 2011. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 106: 1433-40.
10. 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-80.
11. Bouillon, R., Carmeliet, G., Verlinden, L. et al. 2008. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 29: 726-76.
12. Boyle, M. P., Noschese, M. L., Watts, S. L. et al. 2005. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 172: 212-7.
13. Brincourt, J. 1969. [Liquefying effect on suppurations of an oral dose of calciferol]. Presse Med 77: 467-70.
14. Bruce, D., Ooi, J. H., Yu, S., Cantorna, M. T. 2010. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 235: 921-7.
15. Bruce, D., Yu, S., Ooi, J. H., Cantorna, M. T. 2011. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 23: 519-28.
16. Camargo, C. A., Jr., Rifas-Shiman, S. L., Litonjua, A. A. et al. 2007. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 85: 788-95.
17. Cannell, J. J., Vieth, R., Umhau, J. C. et al. 2006. Epidemic influenza and vitamin D. Epidemiol Infect 134: 1129-40.
18. Cantorna, M. T. 2011. Why do T cells express the vitamin D receptor? Ann N Y Acad Sci 1217: 77-82.
19. Chesney, R. W. 2010. Vitamin D and the Magic Mountain: The anti-infectious role of the vitamin. J Pediatr 156: 698-703.
20. Chesney, R. W. 2012a. New thoughts concerning the epidemic of rickets: Was the role of alum overlooked? Pediatr Nephrol 27: 3-6.
21. Chesney, R. W. 2012b. Theobald Palm and his remarkable observation: How the sunshine vitamin came to be recognized. Nutrients 4: 42-51.
22. Chromek, M., Brauner, A. 2008. Antimicrobial mechanisms of the urinary tract. J Mol Med (Berl) 86: 37-47.
23. Chromek, M., Slamova, Z., Bergman, P. et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-41.
24. Davies, P. D., Church, H. A., Bovornkitti, S., Charumilind, A., Byrachandra, S. 1988. Altered vitamin D homeostasis in tuberculosis. Int Med Thailand 4: 45-7.
25. Davies, P. D., Church, H. A., Brown, R. C., Woodhead, J. S. 1987. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 71: 341-4.
26. Devereux, G., Wilson, A., Avenell, A., McNeill, G., Fraser, W. D. 2010. A case-control study of vitamin D status and asthma in adults. Allergy 65: 666-7.
27. Dowling, G. B., Prosser Thomas, E. W. 1946. Treatment of lupus vulgaris with calciferol. Lancet 1: 919-22.
28. Dusso, A. S., Kamimura, S., Gallieni, M. et al. 1997. Gamma-interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82: 2222-32.
29. Edlefsen, G. 1901. Zur Aetiologie der Rachitis. Deutsch Aerzte-Zeitg 509(39): 64.
30. Edlefsen, G. 1902. Ueber die Entstehungsursachen de Rachitis und ihre Verwanschaft mit gewissen Infecktionskrankheiten. Deutsch Aerzte-Zeitg 169: 200.
31. Elkin, S. L., Fairney, A., Burnett, S. et al. 2001. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: A cross-sectional study. Osteoporos Int 12: 366-72.
32. Ellman, P., Anderson, K. H. 1948. Calciferol in tuberculous peritonitis with disseminated tuberculosis. Br Med J 1: 394.
33. Erkkola, M., Kaila, M., Nwaru, B. I. et al. 2009. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy 39: 875-82.
34. Fagan, D. L., Prehn, J. L., Adams, J. S., Jordan, S. C. 1991. The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: Marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3. Mol Endocrinol 5: 179-86.
35. Findlay, L. 1915. The etiology of rickets: A statistical study of the home conditions of 400 to 500 rachitic children. Lancet 185: 956-60.
36. Finklea, J. D., Grossmann, R. E., Tangpricha, V. 2011. Vitamin D and chronic lung disease: A review of molecular mechanisms and clinical studies. Adv Nutr 2: 244-53.
37. Gibney, K. B., MacGregor, L., Leder, K. et al. 2008. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 46: 443-6.
38. Ginde, A. A., Mansbach, J. M., Camargo, C. A., Jr. 2009a. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-90.
39. Ginde, A. A., Mansbach, J. M., Camargo, C. A., Jr. 2009b. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 9: 81-7.
40. Ginde, A. A., Scragg, R., Schwartz, R. S., Camargo, C. A., Jr. 2009c. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57: 1595-603.
41. Hall, W. B., Sparks, A. A., Aris, R. M. 2010. Vitamin D deficiency in cystic fibrosis. Int J Endocrinol 2010: 218691.
42. Hansdottir, S., Monick, M. M. 2011. Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm 86: 217-37.
43. Hansdottir, S., Monick, M. M., Hinde, S. L. et al. 2008. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181: 7090-9.
44. Hansdottir, S., Monick, M. M., Lovan, N. et al. 2010. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 184: 965-74.
45. Harrington, L. E., Hatton, R. D., Mangan, P. R. et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-32.
46. Haworth, C. S., Selby, P. L., Horrocks, A. W. et al. 2002. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 57: 719-23.
47. Henderson, R. C., Madsen, C. D. 1996. Bone density in children and adolescents with cystic fibrosis. J Pediatr 128: 28-34.
48. Hertting, O., Holm, A., Luthje, P. et al. 2010. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One 5: e15580.
49. Herzog, R., Cunningham-Rundles, S. 2011. Immunologic impact of nutrient depletion in chronic obstructive pulmonary disease. Curr Drug Targets 12: 489-500.
50. Hewison, M. 2012. Vitamin D and immune function: An overview. Proc Nutr Soc 71: 50-61.
51. Hewison, M., Burke, F., Evans, K. N. et al. 2007. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103: 316-21.
52. Hill, A. B. 1965. The environment and disease: Association or causation? Proc R Soc Med 58: 295-300.
53. Holick, M. F. 2007. Vitamin D deficiency. N Engl J Med 357: 266-81.
54. Holick, M. F. 2008. Vitamin D: A D-lightful health perspective. Nutr Rev 66: S182-94.
55. Holt, L. E., Howland, J. 1911. Rickets (Rachitis). In: Holt L. E. (ed.) The Diseases of Infancy and Childhood, 6th ed. Appleton, New York: 241-60.
56. Hope-Simpson, R. E. 1983. Recognition of historic influenza epidemics from parish burial records: A test of prediction from a new hypothesis of influenzal epidemiology. J Hyg (Lond) 91: 293-308.
57. Hope-Simpson, R. E. 1992. The Transmission of Epidemic Influenza. Plenum Press, New York.
58. Hughes, A. M., Lucas, R. M., Ponsonby, A. L. et al. 2010. The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: An Australian multicenter study. Pediatr Allergy Immunol 22: 327-33.
59. Imazeki, I., Matsuzaki, J., Tsuji, K., Nishimura, T. 2006. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res 27: 1-9.
60. Iovane, A., Forte, S. 1907. Contributo sperimentale allo studio della etiologia e patogenesi del rachitismo. Pediatria 15: 641.
61. Jenner, W. 1895. Clinical Lectures and Essays on Rickets, Tuberculosis, Abdominal Tumours and Other Subjects. Rivington, Percival, London.
62. Khajavi, A., Amirhakimi, G. H. 1977. The rachitic lung: Pulmonary findings in 30 infants and children with malnutritional rickets. Clin Pediatr (Phila) 16: 36-8.
63. Koch, J. 1914. Ueber experimentelle Rachitis. Berl klin Wochenschr 51: 773.
64. Krutzik, S. R., Hewison, M., Liu, P. T. et al. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181: 7115-20.
65. Laaksi, I., Ruohola, J. P., Tuohimaa, P. et al. 2007. An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86: 714-7.
66. Lemire, J. M. 1992. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49: 26-31.
67. Li-Ng, M., Aloia, J. F., Pollack, S. et al. 2009. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 137: 1396-404.
68. Litonjua, A. A., Weiss, S. T. 2007. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 120: 1031-5.
69. Lubani, M. M., al-Shab, T. S., al-Saleh, Q. A. et al. 1989. Vitamin-D-deficiency rickets in Kuwait: The prevalence of a preventable disease. Ann Trop Paediatr 9: 134-9.
70. Marshall, T. G. 2008. Vitamin D discovery outpaces FDA decision making. Bioessays 30: 173-82.
71. Martineau, A. R., Nhamoyebonde, S., Oni, T. et al. 2011a. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A 108: 19013-7.
72. Martineau, A. R., Timms, P. M., Bothamley, G. H. et al. 2011b. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 377: 242-50.
73. Martineau, A. R., Wilkinson, R. J., Wilkinson, K. A. et al. 2007. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176: 208-13.
74. Mathieu, C., Adorini, L. 2002. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8: 174-9.
75. Mathieu, C., van Etten, E., Decallonne, B. et al. 2004. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 89-90: 449-52.
76. Mellanby, E. 1919. An experimental investigation on rickets. Lancet I: 407-12.
77. Modlin, R. L., Cheng, G. 2004. From plankton to pathogen recognition. Nat Med 10: 1173-4.
78. Morcos, M. M., Gabr, A. A., Samuel, S. et al. 1998. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 137: 157-64.
79. Morpurgo, B. 1902. Durch Infection hervorgerufene malacische und rachitische Skelettveranderungen an jungen weissen Ratten. Centralb f allg Path u path Anat 13: 113.
80. Moussu, G. 1903. Anatomie et physiologie pathologiques de la cachexie osseuse du porc. Bull Soc centr de méd vét n. s. 21: 303.
81. Muhe, L., Lulseged, S., Mason, K. E., Simoes, E. A. 1997. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 349: 1801-4.
82. Nielsen, N. O., Skifte, T., Andersson, M. et al. 2010. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 104: 1487-91.
83. Nnoaham, K. E., Clarke, A. 2008. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int J Epidemiol 37: 113-9.
84. O’Kelly, J., Hisatake, J., Hisatake, Y. et al. 2002. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 109: 1091-9.
85. O’Sullivan, B. P., Freedman, S. D. 2009. Cystic fibrosis. Lancet 373: 1891-904.
86. Park, E. A. 1923. The etiology of rickets. Physiol Rev 3: 106-63.
87. Pfleiderer, M., Lower, J., Kurth, R. 2001. Cold-attenuated live influenza vaccines, a risk-benefit assessment. Vaccine 20: 886-94.
88. Pichler, J., Gerstmayr, M., Szepfalusi, Z. et al. 2002. 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 52: 12-18.
89. Pincikova, T., Nilsson, K., Moen, I. E. et al. 2011. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr 65: 102-9.
90. Pindjakova, J., Hanley, S. A., Duffy, M. M. et al. 2012. Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction. Kidney Int 81: 379-90.
91. Prehn, J. L., Fagan, D. L., Jordan, S. C., Adams, J. S. 1992. Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3. Blood 80: 2811-16
92. Realegeno, S., Modlin, R. L. 2011. Shedding light on the vitamin D-tuberculosis-HIV connection. Proc Natl Acad Sci U S A 108: 18861-2.
93. Richards, J. B., Valdes, A. M., Gardner, J. P. et al. 2007. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 86: 1420-5.
94. Rovner, A. J., Stallings, V. A., Schall, J. I., Leonard, M. B., Zemel, B. S. 2007. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 86: 1694-9.
95. Sabetta, J. R., DePetrillo, P., Cipriani, R. J. et al. 2010. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5: e11088.
96. Sexton, P., Harrison, A. C. 2008. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31: 1322-33.
97. Shaman, J., Jeon, C. Y., Giovannucci, E., Lipsitch, M. 2011. Shortcomings of vitamin D-based model simulations of seasonal influenza. PLoS One 6: e20743.
98. Slomski, A. 2011. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 305: 453-4, 6.
99. Stephenson, A., Brotherwood, M., Robert, R. et al. 2007. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 85: 1307-11.
100. Tang, J., Zhou, R., Luger, D. et al. 2009. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182: 4624-32.
101. Torre, D., Speranza, F., Giola, M. et al. 2002. Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol 9: 348-51.
102. Urashima, M., Segawa, T., Okazaki, M. et al. 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91: 1255-60.
103. Veldman, C. M., Cantorna, M. T., DeLuca, H. F. 2000. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374: 334-8.
104. Walker, V. P., Modlin, R. L. 2009. The vitamin D connection to pediatric infections and immune function. Pediatr Res 65: 106R-13R.
105. Wayse, V., Yousafzai, A., Mogale, K., Filteau, S. 2004. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr 58: 563-7.
106. Wejse, C., Gomes, V. F., Rabna, P. et al. 2009. Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 179: 843-50.
107. Yamshchikov, A. V., Desai, N. S., Blumberg, H. M., Ziegler, T. R., Tangpricha, V. 2009. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 15: 438-49.
108. Yamshchikov, A. V., Kurbatova, E. V., Kumari, M. et al. 2010. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 92: 603-11.
109. Yu, S., Cantorna, M. T. 2008. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105: 5207-12.
110. Yu, S., Zhao, J., Cantorna, M. T. 2011. Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation. J Immunol 187: 4907-12.
111. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-95.
112. Zasloff, M. 2006. Fighting infections with vitamin D. Nat Med 12: 388-90.
113. Zasloff, M. 2007. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810-6.